Pravinu Dugel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ocular Therapeutix™ Reports First Quarter 2024 Results

Ocular Therapeutix™ Reports First Quarter 2024 Results
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesPravinu dugelExchange commissionAboutoculartherapeutix incOcular therapeutix incReports first quarterLeadership appointments put ocularPatient enrollmentFirst subjects randomizedSupport operations intoCash balanceInvestor dayOutline updated corporateExecutive chairmanChief executive officer

Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024

Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMadhoosudan patilSanjay nayakChintan patelPravinu dugelResearch developmentNonclinical developmentExchange commissionPanel titleAssociation for researchOcular therapeutix incAboutoculartherapeutix incSeattle convention centerCompany phaseTwo ophthalmology meetingsOphthalmology innovation source

Ocular Therapeutix™ Announces Board of Directors and Leadership Updates

Ocular Therapeutix™ Announces Board of Directors and Leadership Updates
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Drexel universityUnited statesColumbia universityNew yorkCity ofUnited kingdomCzech republicBoston universityBorough of bedfordSanjay nayakPravinu dugelPeter jarrettAllergan abbvieJoyce allaireAntony mattessichPeterk kaiser

Ocular Therapeutix Reports Inducement Grants Under Nasdaq

BEDFORD, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing.

Donald notmanPravinu dugelJoyce allaireSanjay nayakCompensation committee of ocularOcular therapeutix incExecutive chairmanChief strategy officerCompensation committeeStock incentive planNasdaq listing ruleNasdaq global marketStock incentiveOcular therapeutixNasdaq oculOcular therapeutix

Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Chairman and Chief Strategy Officer

Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Chairman and Chief Strategy Officer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Pravinu dugelSanjay nayakDonald notmanJoyce allaireCompensation committee of ocularOcular therapeutix incNewly appointed executive chairmanChief strategyExecutive chairmanChief strategy officerCompensation committeeStock incentive planNasdaq listing ruleNasdaq global marketStock incentiveOcular therapeutix